Nantahala Capital Management »

Janux Therapeutics shares owned by Nantahala Capital Management

Quarter-by-quarter ownership of Janux Therapeutics (JANX) shares owned by Nantahala Capital Management from 13F filings

Historical chart of Nantahala Capital Management investment in Janux Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Janux Therapeutics held by Nantahala Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Janux Therapeutics by Nantahala Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $11M 810k 13.90

More positions owned by Nantahala Capital Management

Ishares Tr Russell 2000 Etf Put Option (IWM)
Peloton Interactive Cl A Com (PTON)
Herbalife Com Shs (HLF)
Hilton Grand Vacations (HGV)
Soleno Therapeutics (SLNO)
Ban (TBBK)
Viatris Call Option (VTRS)
Edwards Lifesciences Put Option (EW)
Bioventus Com Cl A (BVS)
Establishment Labs Holdings Ord (ESTA)
Uniqure Nv SHS (QURE)
Teva Pharmaceutical Inds Sponsored Ads Call Option (TEVA)
Savara (SVRA)
Spdr Series Trust State Street Spd Put Option (XBI)
Xtant Med Hldgs Com New (XTNT)

View all positions for Nantahala Capital Management

Top funds holding Janux Therapeutics

RA Capital Management
BlackRock
Henderson Group
State Street Corporation
FMR
Vanguard Group
Prosight Management
Vanguard Capital Management
TCG Crossover Management
Wellington Management Company
Alyeska Investment Group
Vanguard Portfolio Management
Deep Track Capital
Point72 Asset Management
Geode Capital Management

View all funds holding Janux Therapeutics